Lee Y S, Han K S, Lee M G
College of Pharmacy, Seoul National University, San 56-1, Shinlim-Dong, Kwanak-Gu, Seoul 151-742, Republic of Korea.
Biopharm Drug Dispos. 1999 May;20(4):225-9. doi: 10.1002/(sici)1099-081x(199905)20:4<225::aid-bdd176>3.0.co;2-e.
Gender differences in pharmacokinetics and pharmacodynamics of azosemide were evaluated after intravenous, 10 mg kg(-1), and oral, 10 mg kg(-1), administration to male and female rats. After intravenous administration to male rats, the percentages of intravenous dose of azosemide recovered from entire gastrointestinal tract at 24 h (13.2 versus 3.93%) was significantly greater than those in female rats. In male rats, the nonrenal clearance of azosemide tended (p<0.066) to be faster and kidney weight tended (p<0.068) to be greater than those in female rats. After oral administration of azosemide to male rats, the 8-h urinary excretion of potassium (0.395 versus 0.766 mmol g(-1) kidney) and 8-h kaluretic efficiency (55.9 versus 284 mmol mg(-1)) decreased significantly compared with female rats.
对雄性和雌性大鼠静脉注射(10 mg kg⁻¹)和口服(10 mg kg⁻¹)阿佐塞米后,评估了其药代动力学和药效学的性别差异。雄性大鼠静脉注射后,24小时从整个胃肠道回收的阿佐塞米静脉剂量百分比(13.2%对3.93%)显著高于雌性大鼠。在雄性大鼠中,阿佐塞米的非肾清除率倾向于(p<0.066)更快,肾脏重量倾向于(p<0.068)大于雌性大鼠。雄性大鼠口服阿佐塞米后,与雌性大鼠相比,钾的8小时尿排泄量(0.395对0.766 mmol g⁻¹肾脏)和8小时利钾效率(55.9对284 mmol mg⁻¹)显著降低。